Detalhe da pesquisa
1.
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.
Breast Cancer Res Treat
; 196(3): 571-581, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280642
2.
Chitosan-silane sol-gel hybrid thin films with controllable layer thickness and morphology.
Carbohydr Polym
; 93(1): 285-90, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23465932